Corporate Governance

Mayne Pharma's Corporate Governance Policies

2020 Corporate Governance Statement (PDF)
Anti-Bribery & Anti-Corruption Policy (PDF)
Audit & Risk Committee Charter (PDF)
Board Charter (PDF)
Business Code of Conduct (PDF)
Communications Policy (PDF)
Continuous Disclosure Policy (PDF)
Diversity Policy (PDF)
Misconduct & Whistleblowing Policy (PDF)
Nomination Committee Charter (PDF)
Remuneration and People Committee Charter (PDF)
Risk Management Framework (PDF)
Science, Technology and Medical Committee Charter (PDF)
Securities Trading Policy (PDF)

Equal Opportunity 2019-2020 Report

In accordance with the requirements of the Workplace Gender Equality Act 2012, on 30 July 2020, Mayne Pharma lodged its annual compliance report with the Workplace Gender Equality Agency.

Equal Opportunity 2019-2020 Report